-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
PharmaCyte Biotech, Inc. quarterly/annual Revenues history and growth rate from 2010 to 2023.
- PharmaCyte Biotech, Inc. Revenues for the quarter ending July 31, 2024 was $0.000.
- PharmaCyte Biotech, Inc. Revenues for the twelve months ending July 31, 2024 was $0.000.
- PharmaCyte Biotech, Inc. annual Revenues for 2023 was $0.000.
- PharmaCyte Biotech, Inc. annual Revenues for 2022 was $0.000.
- PharmaCyte Biotech, Inc. annual Revenues for 2021 was $0.000.